甲状腺癌合并肺结节一例报告及文献复习-现代医学

甲状腺癌合并肺结节一例报告及文献复习

单位：1. 潍坊医学院临床医学院, 山东潍坊 261053;
2. 山东第一医科大学第一附属医院(山东省千佛山医院) 内分泌病学与代谢病学科;山东省风湿免疫病转化医学重点实验室;山东省肾脏病研究所, 山东济南 250014;
3. 济宁医学院, 山东济宁 272000

关键词：甲状腺癌肺结节甲状腺球蛋白放射性碘治疗病例报告

分类号：R736.1

出版年·卷·期（页码）：2023·51·第二期（225-231）

摘要：

甲状腺癌是内分泌系统中最常见的恶性肿瘤，分化型甲状腺癌是最常见的甲状腺恶性肿瘤，经手术及放射性碘治疗等规范治疗后大部分预后良好，仍有约1%~23%的患者会发生远处转移，远处转移以肺部最为常见，合并肺结节的甲状腺癌患者容易发生误诊。本文报道我院[山东第一医科大学第一附属医院（山东省千佛山医院）]收治的1例68岁女性患者，甲状腺癌术后发现多发肺结节，合并颈部淋巴结转移，行多次服碘治疗，甲状腺球蛋白在治疗过程中有所反复，后经肺穿刺，未发现肿瘤细胞。在回顾国内外相关文献的基础上，本文对该类疾病的诊断作进一步探讨，旨在增加对该疾病的重视，减少误诊，从而提高诊治水平。

Thyroid cancer is the most common malignant tumor in the endocrine system, and differentiated thyroid cancer is the most common thyroid malignant tumor. After standard treatment such as surgery and radioiodine therapy, most of the patients have achieved a good prognosis, but about 1%~23% of the patients still have distant metastasis, which is most commonly found in the lungs. Because the thyroid cancer patients complicated with pulmonary nodules are prone to misdiagnosis, in this paper we reported a 68-year-old female patient admitted to our hospital. After thyroid cancer surgery, multiple pulmonary nodules were found with cervical lymph node metastasis. Repeated iodine treatment was performed, and thyroglobulin increased repeatedly during the treatment. After lung puncture, no tumor cells were found. Based on the reviews of relevant literature both at home and abroad, we further studied and discussed the diagnosis of this disease, which is aimed to draw clinicians' attention to this disease, reduce misdiagnosis and improve the level of diagnosis and treatment.

参考文献：

[1] VACCARELLA S, DAL MASO L, LAVERSANNE M, et al.The impact of diagnostic changes on the rise in thyroid cancer incidence:a population-based study in selected high-resource countries[J].Thyroid, 2015, 25(10):1127-1136.
[2] ¹³¹I治疗分化型甲状腺癌指南(2021版)[J].中华核医学与分子影像杂志, 2021, 41(04):218-241.
[3] ZHAO T, LIANG J, LI T, et al.Serial stimulated thyroglobulin measurements are more specific for detecting distant metastatic differentiated thyroid cancer before radioiodine therapy[J].Chin J Cancer Res, 2017, 29(3):213-222.
[4] 申江玉, 晋建华.分化型甲状腺癌肺转移的研究进展[J].国际放射医学核医学杂志, 2021, 45(10):663-668.
[5] SCOTT E, LEAROYD D, CLIFTON-BLIGH R J.Therapeutic options in papillary thyroid carcinoma:current guidelines and future perspectives[J].Future Oncol, 2016, 12(22):2603-2613.
[6] 赫捷, 李进, 程颖, 等.中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021[J].肿瘤预防与治疗, 2021, 34(12):1164-1201.
[7] 吴旻, 夏欢, 王新华, 等.肺转移性甲状腺癌碘治疗耐受的危险因素及患者生存情况分析[J].现代医学, 2019, 47(10):1260-1262.
[8] LUBITZ C C, SOSA J A.The changing landscape of papillary thyroid cancer:Epidemiology, management, and the implications for patients[J].Cancer, 2016, 122(24):3754-3759.
[9] MASAKI C, SUGINO K, SAITO N, et al.Efficacy and limitations of lenvatinib therapy for radioiodine-refractory differentiated thyroid cancer:real-world experiences[J].Thyroid, 2020, 30(2):214-221.
[10] 黄韬, 胡丽丽, 周军.难治性分化型甲状腺癌的研究进展[J].东南大学学报(医学版), 2017, 36(5):876-881.
[11] 刘惠惠, 王水利, 晋瞾, 等.甲状腺癌并肺部转移误诊为粟粒型肺结核并文献回顾[J].临床肺科杂志, 2016, 21(8):1545-1547.
[12] CHENG L, SA R, LUO Q, et al.Unexplained hyperthyroglobulinemia in differentiated thyroid cancer patients as an indication for radioiodine adjuvant therapy:a prospective multicenter study[J].J Nucl Med, 2021, 62(1):62-68.
[13] ZHAO T, LIANG J, LI T, et al.Value of serial preablative thyroglobulin measurements:can we address the impact of thyroid remnants?[J].Nucl Med Commun, 2016, 37(6):632-639.
[14] ZHAO T, LIANG J, LI T, et al.Relationship between variation of pre-ablation stimulated thyroglobulin and distant metastasis in patients with differentiated thyroid cancer[J].Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2015, 37(3):315-319.
[15] TAM S, AMIT M, BOONSRIPITAYANON M, et al.Adjuvant external beam radiotherapy in locally advanced differentiated thyroid cancer[J].JAMA Otolaryngol Head Neck Surg, 2017, 143(12):1244-1251.
[16] PICCARDO A, ARECCO F, PUNTONI M, et al.Focus on high-risk DTC patients:high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survival[J].Clin Nucl Med, 2013, 38(1):18-24.
[17] TIAN T, XU Y, ZHANG X, et al.Prognostic implications of preablation stimulated Tg:A retrospective analysis of 2500 thyroid cancer patients[J].J Clin Endocrinol Metab, 2021, 106(11):e4688-e4697.
[18] BERTAGNA F, BOSIO G, BIASIOTTO G, et al.F-18 FDG-PET/CT evaluation of patients with differentiated thyroid cancer with negative I-131 total body scan and high thyroglobulin level[J].Clin Nucl Med, 2009, 34(11):756-761.
[19] ZILIOLI V, PELI A, PANAROTTO M B, et al.Differentiated thyroid carcinoma:Incremental diagnostic value of(131)I SPECT/CT over planar whole body scan after radioiodine therapy[J].Endocrine, 2017, 56(3):551-559.
[20] SCHMID D, SZIKSZAI A, LINKE R, et al.Impact of¹³¹I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation[J].J Nucl Med, 2009, 50(1):18-23.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录